机构:[1]Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China河北医科大学第四医院[2]Hebei Med Univ, Hosp 4, Dept Hematol, Shijiazhuang, Peoples R China临床科室血液内科河北医科大学第四医院[3]Hebei Med Univ, Hosp 4, Hebei Tumor Hosp, Dept Hematol, Shijiazhuang, Peoples R China临床科室血液内科河北医科大学第四医院[4]Hebei Med Univ, Hosp 4, Hebei, Peoples R China河北医科大学第四医院[5]Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
第一作者机构:[1]Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
推荐引用方式(GB/T 7714):
Zhang Wenqi,Gao Yuhuan,Diao Lanping,et al.Molecular Mechanistic Insights and Real-World Clinical Outcomes of Selinexor in Diffuse Large B-Cell Lymphoma[J].BLOOD.2024,144:6184-6185.doi:10.1182/blood-2024-203366.
APA:
Zhang, Wenqi,Gao, Yuhuan,Diao, Lanping,Liu, Lihong,Ma, Guangyu...&Huang, Chen.(2024).Molecular Mechanistic Insights and Real-World Clinical Outcomes of Selinexor in Diffuse Large B-Cell Lymphoma.BLOOD,144,
MLA:
Zhang, Wenqi,et al."Molecular Mechanistic Insights and Real-World Clinical Outcomes of Selinexor in Diffuse Large B-Cell Lymphoma".BLOOD 144.(2024):6184-6185